Edlyn Wu

Edlyn Wu

Business Development and Marketing

Dr. Edlyn Wu earned her PhD in Biochemistry from McGill University in Canada, investigating the mechanisms for how small RNA molecules interfere with protein synthesis. She then moved to Europe for her postdoctoral research at the Max Planck Institute for Molecular Cell Biology and Genetics in Dresden, Germany, before moving with the lab to the Université de Lausanne in Switzerland.

Throughout her academic career, Edlyn has actively engaged in scientific communication initiatives, working to make complex scientific concepts and research stories accessible to broader audiences. Eager to expand her impact beyond traditional bench research, she transitioned to industry by joining Atinary Technologies. In her role in business development, marketing, and communications, she draws on her deep understanding of the challenges scientists face at the bench to bridge the gap between researchers and cutting-edge digital technologies that support and enable scientific innovation.

Check out my interview on Lormina!

Research interests: Molecular Biology, Developmental Biology, Gene Regulation, Self-driving labs, AI-driven R&D

  • Accelerating Hydroformylation R&D with AI for Resource Efficiency

    Edlyn Wu/
    January 17, 2026
  • Leveraging HTE to optimize yield in deprotection reaction with Takeda Pharmaceuticals

    Edlyn Wu/
    February 6, 2026
  • Optimizing HPLC method development to maximize peak resolution

    Edlyn Wu/
    February 6, 2026
  • Maximizing yield and minimizing cost in oligonucleotide synthesis with Snapdragon Chemistry

    Edlyn Wu/
    February 6, 2026
  • Optimizing Catalyst Formulation for CO2 to Methanol Conversion with ETH Zurich

    Edlyn Wu/
    January 26, 2026
  • Maximizing Yield and Conversion in Chemical Synthesis with IBM Research Europe

    Edlyn Wu/
    January 29, 2026
  • Smart Chemical Library Screening and Ligand Optimization

    Edlyn Wu/
    January 26, 2026
  • Automated Optimization of Perovskite Solar Cells with ViperLab

    Edlyn Wu/
    January 26, 2026
  • Atinary and SwissCAT+ Showcase the Future of Materials Discovery

    Edlyn Wu/
    January 27, 2026
  • Inside Atinary’s New Biopôle Office and Team Culture

    Edlyn Wu/
    February 4, 2026
  • Atinary and Chemspeed’s Demo Lab Opening

    Edlyn Wu/
    February 4, 2026
  • Atinary, ABB, Mettler-Toledo, and Agilent are building the first Self-Learning and Self-Driving Lab of its kind

    Edlyn Wu/
    February 6, 2026
  • Atinary is now listed on AWS Marketplace

    Edlyn Wu/
    February 6, 2026
  • Atinary’s SDLabs Platform is SOC 2 Compliant

    Edlyn Wu/
    February 6, 2026
  • Atinary Joins the AWS Partner Network

    Edlyn Wu/
    February 6, 2026
  • Dr. Stephen Buchwald Joins Atinary’s Advisory Board

    Edlyn Wu/
    February 6, 2026
  • Harnessing AI to Accelerate Breakthroughs in Metal-Based Antibiotic Discovery

    Edlyn Wu/
    February 6, 2026
  • Atinary adds artificial chemical intelligence expert to its Scientific Advisory Board

    Edlyn Wu/
    February 6, 2026
  • Advancing T Cell Engineering with AI and Self-Driving Lab technology

    Edlyn Wu/
    January 27, 2026
  • Atinary Inspires High School Students in STEM

    Edlyn Wu/
    January 26, 2026
  • Bayesian Optimization for Resource-Efficient Hydroformylation

    Edlyn Wu/
    February 5, 2026
  • Atinary’s Multi-Fidelity ML Algorithm Now Published

    Edlyn Wu/
    February 4, 2026
  • New machine learning research article from Atinary

    Edlyn Wu/
    February 6, 2026
  • New publication for Atinary and IBM Research

    Edlyn Wu/
    February 6, 2026
  • New publication for Atinary in Chimia

    Edlyn Wu/
    February 6, 2026
  • Shaping the Future of R&D teams with AI and Self-Driving Labs | Atinary Webinar Series Ep04

    Edlyn Wu/
    February 6, 2026
  • DMTA Innovation at Takeda | Atinary Webinar Series Ep03

    Edlyn Wu/
    February 6, 2026
  • Closing the loop in R&D with AI | Atinary Webinar Series Ep 02

    Edlyn Wu/
    February 6, 2026